Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04099030 · ClinicalTrials.gov registry record
Effect of Opioid Shortage on Drug Selection
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 1,668
- Enrollment target
NCT04099030: Completed study, sponsored by Wake Forest University Health Sciences.
NCT04099030 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,668 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04099030 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 1,668 participants
- Enrollment target
Study Summary
This study will look at the effects of fentanyl shortage in laparoscopic cholecystectomy cases. The opioid shortage, specifically hydromorphone and fentanyl, caused a decrease in administration of opioid analgesia for laparoscopic cholecystectomy intraoperatively.
Primary Outcome
Monthly average amount administered per case per kg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,668 participants |
| Start Date | 2019-04-05 |
| Est. Completion | 2019-12-13 |
What the finished NCT04099030 record still lists
NCT04099030 is an observational study that tracks outcomes without assigning an intervention. Its 1,668 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04099030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04099030 about?
NCT04099030 is a clinical study titled "Effect of Opioid Shortage on Drug Selection". This study will look at the effects of fentanyl shortage in laparoscopic cholecystectomy cases. The opioid shortage, specifically hydromorphone and fentanyl, caused a decrease in administration of opioid analgesia for laparoscopic cholecystectomy intraoperatively.
What is the current status of trial NCT04099030?
This trial is currently completed. The enrollment target is 1,668 participants. The study started on 2019-04-05. Estimated completion is 2019-12-13.
Who is sponsoring clinical trial NCT04099030?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI